Find Your Option With ScriptsMD Medications like semaglutide have changed how people approach weight loss
This is the only door open to you before you become a patient
The mechanism might be related to blood pressure changes or the flushing effect
We need a more sophisticated conversation about pharmaceutical value rather than killing the golden goose, especially given that we all want the benefits
Compounded tirzapetide is no longer on the market, and compounded semaglutide will be removed by April 22 for state-licensed 503A pharmacies or May 22 for larger 503B pharmacies
In the ATTAIN-1 trial of orforglipron, the most common adverse events were nausea (2133% depending on dose), constipation (2129%), diarrhea (2123%), vomiting (1324%), and heartburn